Admera Health offers fast and scalable COVID19 testing for monitoring active infections to limit additional exposures.
- Rapid results
- Accurate results with high sensitivity and specificity
- Individual and batch results available via a portal
- Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA)
Admera Health offers fast and scalable COVID19 testing for monitoring active infections to limit additional exposures.
- Rapid results
- Accurate results with high sensitivity and specificity
- Individual and batch results available via a portal
- Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA)
Admera Health provides high-integrity end-to-end
pharmacogenomics solutions
Pharmacogenomics: Genetics for Smarter Medication Management Against COVID-19
PGxOne™ Plus is a comprehensive pharmacogenomics test that can help select appropriate medications for patients with pre-existing comorbidities (cardiovascular diseases, diabetes, chronic respiratory disease, and others), patients with high-risk genotypes, as well as helping select both medications proposed to treat COVID-19 and those involved with patient supportive care.
Inquire About Testing
Please fill out the form on the right to learn more about the Clarifi COVID-19 Test offered by Admera Health and/or the PGxOne™ Plus pharmacogenomics test.
Alternatively, you may call us directly at 908-222-0533 followed by Option 3 to speak with a member of the Admera Health Business Development team.
Please fill out the form below to learn more about the Clarifi COVID-19 Test offered by Admera Health and/or the PGxOne™ Plus pharmacogenomics test.
Alternatively, you may call us directly at 908-222-0533 followed by Option 3 to speak with a member of the Admera Health Business Development team.